This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Compares the volatility characteristics of risk parity against index funds in retirement planning, highlighting stability and risk exposure.
27,630 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A confrontation at the Oscars put private security in the spotlight and underscored how security budgeting, liability...
The U.S. pressed a tenth consecutive night of airstrikes on Iran as shipping in the Hormuz Strait faced renewed risk,...
Investors have long looked to deals to jumpstart Netflix's growth. Five paraphrased lines from Netflix's co-CEO revea...
AI-driven capital spending and the wealth boost from tech stocks are accelerating U.S. GDP growth. Analysts say the d...
A new study finds that widespread AI adoption is arming workers with more tasks but leaving them exhausted and less p...
A new Colorado bill could tax income that doesn't really exist by altering how the AMT and net operating losses are t...
Morgan Stanley files an amended S-1 for MSBT, signaling a concerted push to launch a spot Bitcoin ETF and disrupt the...
Elon Musk announced a Texas-based Terafab chip initiative, a joint venture between TESLA and SPACE X, to build advanc...
Defense technology is approaching a market shakeout as government procurement reforms accelerate purchases and ventur...
A mom of four faced big financial odds when her spouse traveled for work. This story explains how she built a 4-renta...
A long-remembered jab about Chrome’s prospects resurfaces as the browser landscape continues to evolve. Here’s what i...